Promoter Group to Sell 2.81% Stake in Crop Life Science Limited via On-Market Transaction
Crop Life Science Limited has announced a planned share transfer involving members of its promoter group, who plan to sell 4,80,000 equity shares through an on-market transaction. The shares are being purchased by the company's Whole-Time Director, Mr. Chunilal Samjubhai Virolia.The proposed sale involves three individuals from the promoter group: RAJESHKUMAR VRAJLAL LUNAGARIYA, VIJAYABEN A LUNAGARIA, and SUMITABEN RAJESHKUMAR LUNAGARIA. The transaction is set to take place through the stock exchange market and does not involve the issuance of any new shares by Crop Life Science Limited.
The sale constitutes 2.81% of the paid-up equity share capital of the company. Mr. Chunilal Samjubhai Virolia, who serves as a Whole-Time Director of the Company, is designated as the buyer or transferee for these shares.
Details regarding the seller-wise transfer are presented below:
| Seller | Number of Shares |
|---|---|
| RAJESHKUMAR VRAJLAL LUNAGARIYA | 1,76,000 |
| VIJAYABEN A LUNAGARIA | 1,12,000 |
| SUMITABEN RAJESHKUMAR LUNAGARIYA | 1,92,000 |
| Total | 4,80,000 |
The proposed transaction is scheduled to be completed between Thursday, July 02, 2026, and Friday, July 03, 2026.
Regarding the company's operational stability, the transfer is expected to have no change in management or control of Crop Life Science Limited, as Mr. Chunilal Samjubhai Virolia is already a Whole-Time Director of the Company. The transaction itself does not constitute a related party transaction, as the sale is occurring between the promoter group members and the director/transferee, with the company not being a party to the trade.
CLSL Stock Price Movement
Today, Crop Life Science Limited equity closed unchanged at ₹43.00 per share as the market concluded trading. The stock maintained its stable level throughout the session, reflecting a neutral reception from investors in the agrochemical sector.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.